Creating advanced tools for synthetic biology and genomics
The Assemblatron
This study is working on new ways to create important genetic materials that can help scientists better understand diseases and improve treatments, which could ultimately benefit patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11026344 on NIH RePORTER |
What this research studies
This research focuses on developing innovative methods for generating synthetic nucleic acid constructs, which are essential for advancing biological and biomedical research. By improving nucleic acid synthesis and assembly techniques, the project aims to enhance our understanding of genomics, disease diagnosis, and treatment. Patients may benefit from breakthroughs in disease prevention and treatment as these new tools could lead to significant advancements in medical science and agriculture. The research also includes the development of a user-friendly design platform to facilitate these processes in laboratories.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or those interested in advancements in synthetic biology.
Not a fit: Patients with conditions unrelated to genetic or synthetic biology advancements may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking improvements in the diagnosis and treatment of various diseases.
How similar studies have performed: Previous research in synthetic biology and nucleic acid synthesis has shown promising results, indicating that this approach has the potential for significant advancements.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Boeke, Jef D — New York University School of Medicine
- Study coordinator: Boeke, Jef D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.